Wednesday 12 November 2008

Exit Ipca Lab at Rs 500-550: Agarwal

Sanjeev Agarwal, Head-Equity of Globe Capital Market is of the view that one can exit Ipca Laboratories at Rs 500-550.

Agarwal told CNBC-TV18, "Ipca Laboratories has been showing a very strong strength in the last few sessions and what I feel like Rs 500-550 will be the ideal phase to exit this stock. One should actually shift to a much more volatile stock at this moment because we are near the bottom range and if that recovery comes, definitely one will be making much more money, which has a higher beta. This stock has a particularly very low beta and what I may at this point feel like Rs 550 will be the ideal point to exit this stock and enter into some other stocks, which you are getting much cheaper because of their volatility."

Disclosure: It is safe to assume that analyst and his clients may have an investment interest in the above stock/sector.

Source: Moneycontrol

Posted by Harsh at 09:18

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)
DISCLAIMER: The author is not a registered stockbroker nor a registered advisor and does not give investment advice. His comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to buy or sell a stock, option, future, bond, commodity, index or any other financial instrument at any time. While he believes his statements to be true, they always depend on the reliability of his own credible sources. The author recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, before making any investment decisions, and that you confirm the facts on your own before making important investment commitments.